HLA-G expression in placenta in relation to HLA-G genotype and polymorphisms

American Journal of Reproductive Immunology

Volumn 52, Issue 3, 2004, Pages 212-217

  Hviid, Thomas Vauvert F ^a   Larsen, Lise Grupe ^b   Hoegh, Anne Mette ^c   Bzorek, Michael ^b  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b Section of Endocrinology   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Human leukocyte antigen G; Placenta; Polymorphism; Preeclampsia

Indexed keywords

DNA; HLA G ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE TECHNOLOGY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 5444243182     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2004.00208.x     Document Type: Article

References (29)

1. LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, McCluskey J, Carosella ED: Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 2003; 62:273-284.
2. Le Bouteiller P, Blaschitz A: The functionality of HLA-G is emerging. Immunol Rev 1999; 167:233-244.
3. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC: Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999; 96:5674-5679.
4. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED: Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94:11520-11525.
5. Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y: Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody '87G' and anti-cytokeratin antibody 'CAM5.2'. Am J Reprod Immunol 1996; 36:349-358.
6. Lim KH, Zhou Y, Janatpour M, McMaster M, Bass K, Chun SH, Fisher SJ: Human cytotrophoblast differentiation/ invasion is abnormal in pre-eclampsia. Am J Pathol 1997; 151:1809-1818.
7. Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S: Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000; 6:88-95.
8. Emmer PM, Steegers EA, Kerstens HM, Bulten J, Nelen WL, Boer K, Joosten I: Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum Reprod 2002; 17:1072-1080.
9. Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL: HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci USA 1996; 93:161-165.
10. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR: HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32:311-315.
11. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW: A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993; 2:2200.
12. Hviid TV, Sorensen S, Morling N: Polymorphism in the regulatory region located more than 1.1 kilobases 5′ to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene. Hum Immunol 1999; 60:1237-1244.
13. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T: Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003; 72:1425-1435.
14. O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, Moreau P: Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001; 58:1943-1949.
15. Hviid TV, Hylenius S, Rorbye C, Nielsen LG: HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003; 55:63-79.
16. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H: Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001; 57:15-21.
17. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
18. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB: HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002;60:122-132.
19. Miller RT, Kubier P: Blocking of endogenous avidin-binding activity in immunohistochemistry. The use of egg whites. Appl Immunohistochem 1997; 5:63-66.
20. Fujii T, Ishitani A, Geraghty DE: A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994; 153:5516-5524.
21. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E: An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci USA 1994; 91:4209-4213.
22. Hviid TV, Møller C, Sørensen S, Morling N: Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Human Immunol 1998; 59:87-98.
23. Pfeiffer KA, Fimmers R, Engels G, van der Ven H, van der Ven K: The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001; 7:373-378.
24. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P: The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003; 64:1005-1010.
25. Menier C, Saez B, Horejsi V, Martinozzi S, Krawice-Radanne I, Bruel S, Le Danff C, Reboul M, Hilgert I, Rabreau M, Larrad ML, Pla M, Carosella ED, Rouas-Freiss N: Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class 1 molecules. Hum Immunol 2003; 64:315-326.
26. Schust DJ, Hill AB, Ploegh HL: Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J Immunol 1996; 157:3375-3380.
27. Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE, Ahn K: Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol 2000; 164:805-811.
28. Aikhionbare FO, Hodge T, Kuhn L, Bulterys M, Abrams EJ, Bond VC: Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmission. AIDS 2001; 15:2196-2198.
29. Barel MT, Ressing M, Pizzato N, Van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ: Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J Immunol 2003; 171:6757-6765.